Related Experiment Video
Updated: Dec 30, 2025
Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
MiR-124 inhibits cell proliferation, invasion, and migration in glioma by targeting Smad2
1Department of Neurosurgery, The Third Affiliated Hospital of Harbin Medical University, Heilongjiang Institute for Cancer Research Harbin, Heilongjiang, P. R. China.
Abstract:
Tumorigenesis research has focused on the roles of deregulated microRNAs for many years. The aberrant expression of miR-124 in many tumors has been widely reported, yet its role in glioma formation still needs further research. In this study, the expression and mechanisms of miR-124 in glioma development were explored. We found that glioma cell lines and tumor tissues demonstrated downregulated miR-124 expression, and that cell proliferation, migration, and invasion were reduced when miR-124 was restored. Furthermore, a bioinformatic analysis indicated that Smad2 was a putative target of miR-124, and we confirmed that miR-124 directly targets Smad2 in a luciferase reporter assay system. These results indicate that glioma cell growth is suppressed by miR-124 through its negative regulation of Smad2 expression. Our findings disclose a critical role of miR-124 in glioma pathogenesis, and suggest its potential application for glioma therapy.
Insights
MicroRNA-124 (miR-124) is downregulated in glioma, suppressing tumor growth by targeting Smad2. Restoring miR-124 inhibits glioma cell proliferation, migration, and invasion, suggesting therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators in tumorigenesis.
- Aberrant miR-124 expression is observed in various cancers.
- The specific role of miR-124 in glioma development requires further investigation.
Purpose of the Study:
- To investigate the expression and functional mechanisms of miR-124 in glioma.
- To identify the molecular targets of miR-124 in glioma cells.
- To evaluate the therapeutic potential of miR-124 in glioma.
Main Methods:
- Analysis of miR-124 expression in glioma cell lines and tumor tissues.
- Functional assays assessing cell proliferation, migration, and invasion upon miR-124 restoration.
- Bioinformatic analysis to predict miR-124 targets.
- Luciferase reporter assays to validate direct targeting of Smad2 by miR-124.
Main Results:
- Glioma cell lines and tissues exhibit downregulated miR-124 expression.
- Restoration of miR-124 significantly reduced glioma cell proliferation, migration, and invasion.
- Smad2 was identified as a direct target of miR-124.
- miR-124 suppresses glioma cell growth via negative regulation of Smad2.
Conclusions:
- miR-124 plays a critical role in glioma pathogenesis.
- The miR-124/Smad2 axis is a key pathway in controlling glioma progression.
- miR-124 represents a potential therapeutic target for glioma treatment.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019